ClinicalTrials.Veeva

Menu
P

Palm Beach Research Center | West Palm Beach, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Buprenorphine
Tanezumab
Carisoprodol
Lasmiditan
Peramivir
Lubiprostone
Ibuprofen
Plecanatide
Galcanezumab
BTDS

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 105 total trials

A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

The main purpose of this study is to evaluate the safety and efficacy of donanemab in participants with preclinical Alzheimer's Disease (AD). Approxi...

Enrolling
Alzheimer Disease
Drug: Donanemab
Drug: Placebo

The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participant...

Enrolling
Chronic Migraine
Drug: Placebo
Drug: Galcanezumab

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have o...

Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Retatrutide

The goal of this clinical trial is to learn if a single knee injection of different doses (Dose A and Dose B) of an investigation product PCRX-201, f...

Enrolling
Osteoarthritis (OA) of the Knee
Biological: Enekinragene Inzadenovec (PCRX-201)
Biological: Placebo

The combination drug composed of aroxybutynin and atomoxetine, designated AD109, is being developed by Apnimed for the treatment of obstructive sleep...

Invitation-only
OSA
Drug: Aroxybutynin and Atomoxetine

The main purpose of this study is to compare dose levels of petrelintide versus placebo with regards to effect on body weight, safety, and tolerabili...

Active, not recruiting
Obesity
Drug: Petrelintide
Drug: Placebo

The goal of this randomised, double-blind phase II/III clinical trial is to determine the safety and efficacy of IHL-42X in subjects with obstructive...

Active, not recruiting
Obstructive Sleep Apnea
Drug: Acetazolamide
Drug: IHL-42X Low Dose
New

The purpose of this randomized study is to demonstrate direct clinical benefit, i.e., observed benefits in how humans with COPD feel in terms of symp...

Enrolling
COPD
Smoking
Other: Cigarette
Other: THS

Trial sponsors

Pfizer logo
Lilly logo
Purdue Pharma logo
Allergan logo
Ferring logo
Ironwood Pharmaceuticals logo
Novartis logo
Bausch Health logo
BioCryst logo
B

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems